Syndax Pharmaceuticals 12-Month Price Target Cut to $37.27
The headline reports a cut to the stock’s 12-month price target to $37.27, implying 125% upside.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.